HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: clinchem.2003.026484v1 50/5/846    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (8) Citing Articles via Google Scholar Google Scholar Articles by Hong, K. M. Articles by Press, R. D. Search for Related Content PubMed PubMed Citation Articles by Hong, K. M. Articles by Press, R. D. Related Collections Molecular Diagnostics and Genetics

Quantitative Real-Time PCR with Automated Sample Preparation for Diagnosis and Monitoring of Cytomegalovirus Infection in Bone Marrow Transplant Patients

¹ Department of Pathology, Oregon Health & Science University, Portland, OR 97201.

^aAuthor for correspondence. Fax 503-494-2025; e-mail pressr{at}ohsu.edu.

Background: In bone marrow and stem cell transplant patients, the widespread use of preemptive cytomegalovirus (CMV) antiviral therapy necessitates faster, more precise, and more sensitive quantitative laboratory methods for serial viral load monitoring.

Methods: We developed a novel CMV viral load assay using real-time PCR of plasma DNA prepared by an automated robotic workstation. Fluorescent hybridization probes directed at the glycoprotein B (gB) gene (or EcoRI D region) of CMV were used to detect and quantify PCR products. The ß-globin gene was amplified in parallel to control for the efficiency of the extraction and PCR steps.

Results: The assay was linear (R = 0.999) from a lower detection limit of 125 copies/mL to 5 x 10⁹ copies/mL with a PCR efficiency of 1.975 (gB) or 2.02 (EcoRI D). The viral loads determined by PCRs directed at these two different viral targets were no different (n = 53; R = 0.928). The interassay CV was 3.5%, and the intraassay CV was 1–4%. Compared with a commercially available quantitative competitive PCR assay (Roche MONITOR; R = 0.59), the mean CMV viral load by real-time PCR was 3.1 times higher (mean ratio; P = 0.002). The diagnostic sensitivity and specificity of the real-time assay were 96% and 100%, respectively (n = 147), compared with 74% and 98% for a qualitative PCR assay (Roche AMPLICOR). On a subset of samples, the diagnostic sensitivity of viral culture was no greater than 50% (n = 44). Of 1115 clinical referral samples from 252 patients, 10% of the samples and 18% of the patients had low-level CMV viremia (median, 500 copies/mL). In this predominantly (85%) bone marrow transplant testing cohort, serial CMV viral load results were the predominant clinical trigger for the initiation, monitoring, and cessation of preemptive antiviral therapy.

Conclusions: The combination of automated DNA preparation and semiautomated real-time fluorescent PCR detection allows for a sensitive, precise, and accurate high-throughput assay of CMV viral load that can be used as the laboratory trigger for preemptive antiviral therapy.

The following articles in journals at HighWire Press have cited this article:

				W. Habbal, F. Monem, and B. C. Gartner Comparative evaluation of published cytomegalovirus primers for rapid real-time PCR: which are the most sensitive? J. Med. Microbiol., July 1, 2009; 58(7): 878 - 883. [Abstract] [Full Text] [PDF]

				D. J. Wolff, D. L. Heaney, P. D. Neuwald, K. A. Stellrecht, and R. D. Press Multi-Site PCR-Based CMV Viral Load Assessment-Assays Demonstrate Linearity and Precision, but Lack Numeric Standardization: A Report of the Association for Molecular Pathology J. Mol. Diagn., March 1, 2009; 11(2): 87 - 92. [Abstract] [Full Text] [PDF]

				C. Gimeno, C. Solano, J. C. Latorre, J. C. Hernandez-Boluda, M. A. Clari, M. J. Remigia, S. Furio, M. Calabuig, N. Tormo, and D. Navarro Quantification of DNA in Plasma by an Automated Real-Time PCR Assay (Cytomegalovirus PCR Kit) for Surveillance of Active Cytomegalovirus Infection and Guidance of Preemptive Therapy for Allogeneic Hematopoietic Stem Cell Transplant Recipients J. Clin. Microbiol., October 1, 2008; 46(10): 3311 - 3318. [Abstract] [Full Text] [PDF]

				T. Zhang, S. Grenier, B. Nwachukwu, C. Wei, J. H. Lipton, S. Kamel-Reid, and the Association for Molecular Pathology Hematopath Inter-Laboratory Comparison of Chronic Myeloid Leukemia Minimal Residual Disease Monitoring: Summary and Recommendations J. Mol. Diagn., September 1, 2007; 9(4): 421 - 430. [Abstract] [Full Text] [PDF]

				M. J. Espy, J. R. Uhl, L. M. Sloan, S. P. Buckwalter, M. F. Jones, E. A. Vetter, J. D. C. Yao, N. L. Wengenack, J. E. Rosenblatt, F. R. Cockerill III, et al. Real-Time PCR in Clinical Microbiology: Applications for Routine Laboratory Testing Clin. Microbiol. Rev., January 1, 2006; 19(1): 165 - 256. [Abstract] [Full Text] [PDF]

				M. B. Nye, A. R. Leman, M. E. Meyer, M. A. Menegus, and P. G. Rothberg Sequence Diversity in the Glycoprotein B Gene Complicates Real-Time PCR Assays for Detection and Quantification of Cytomegalovirus J. Clin. Microbiol., October 1, 2005; 43(10): 4968 - 4971. [Abstract] [Full Text] [PDF]

				W. Habbal, F. Monem, and B. C. Gartner Errors in Published Sequences of Human Cytomegalovirus Primers and Probes: Do We Need More Quality Control? J. Clin. Microbiol., October 1, 2005; 43(10): 5408 - 5409. [Full Text] [PDF]